EVOTEC SE INH O.N.
Commented by Stefan Feulner on May 13th, 2021 | 08:55 CEST
Evotec, RYU Apparel, Adidas - This is just the beginning
Earnings season is in full swing. Yesterday, Bayer, Commerzbank and Varta, among others, presented good figures. Despite Corona restrictions and problems in the supply chain, sporting goods manufacturers were also able to deliver significant jumps in sales. Puma increased its sales by 26% in the first quarter. Along with the home office, sports at home or outdoors is the new trend. And this trend is likely to stay even after the pandemic. The potential for the sporting goods industry is enormous.
ReadCommented by Stefan Feulner on April 28th, 2021 | 07:04 CEST
CureVac, PsyBio, Evotec - Revolution in the billion-dollar market!
The anxiety and limitations associated with the coronavirus pose major challenges for people suffering from depression. Officially, around 350 million people worldwide live with depression, but the number of unreported cases is significantly higher. At the moment, the number one cause of the disease is only combated with antidepressants; there are hardly any alternative treatment methods without severe side effects. A completely new field is currently emerging that could completely eclipse existing drugs, with incredible potential for the young companies.
ReadCommented by Stefan Feulner on April 21st, 2021 | 09:30 CEST
Evotec, NSJ Gold, Infineon - The winners of inflation!
Inflation is coming in leaps and bounds. Although the Corona pandemic is not yet over, a strong economic recovery is emerging globally, driven by China and the United States. In the United States, price inflation was 2.6% in March and rising. Nevertheless, the Fed intends to continue its loose monetary policy, which was accelerated during the Corona Crisis, until at least 2023. In doing so, Fed Chairman Powell is overriding the basic principle of a central bank to take preventive action against inflation. There is a threat of monetary devaluation of historic proportions. We show how you can profit from this situation.
ReadCommented by Stefan Feulner on March 25th, 2021 | 08:19 CET
Evotec, PsyBio Therapeutics, MorphoSys - Milestone in Development!
About 350 million people worldwide live with depression. According to estimates by the World Health Organization (WHO), only one in four sufferers receives adequate treatment. With all its limitations, the Corona Crisis has caused the number of unreported cases to skyrocket exorbitantly, making depression the most significant cause of illness above all. Apart from the prescription of antidepressants, which usually have strong side effects, there are few alternative treatment methods. But now, young biotech companies are stepping up to revolutionize the field of "mental health."
ReadCommented by Carsten Mainitz on March 3rd, 2021 | 07:34 CET
Evotec, Cardiol Therapeutics, MorphoSys - Watch out: Great upside potential here in the short term
In the pandemic, investors have learned that small biotech companies, some still with a start-up character, can be worth billions overnight. BioNTech and CureVac are familiar names from the press. Both are linked by the Corona drug and the fact that they are headquartered in Germany. Two other German companies, Evotec and MorphoSys, have written a good growth story on the stock exchange in recent years: small becomes big! Small is also still the Canadian Cardiol Therapeutics. With the announced dual listing on the US technology exchange Nasdaq, a valuation boost could be imminent.
ReadCommented by Stefan Feulner on February 3rd, 2021 | 09:18 CET
Evotec, GS Holdings, TUI - Growth without end!
China's growth is almost uninterrupted. Experts predict that the Middle Kingdom will become the world's largest economy by 2028 at the latest. The fact that China has so far come out of the Corona Crisis in better shape means that the transition is likely to happen even sooner. The tiger economies such as Singapore, Hong Kong and Taiwan will also benefit. The upswing is giving rise to new business models with enormous growth potential for the coming years. We present the latest opportunities one by one.
ReadCommented by Stefan Feulner on January 28th, 2021 | 10:57 CET
Evotec, BIGG Digital Assets, Varta - Watch out for the next wave!
The cryptocurrencies are correcting with a violent fluctuation range. After prices of just under USD 42,000, bitcoin is currently at just over USD 30,000. Where do things go from here? Will the prices fall into the bottomless pit again as they did at the end of 2017, or is it just a longer pause to the next higher move this time. The fact is that bitcoin has come of age. Thus, even institutional investors such as hedge funds and family offices are liking the virtual currency.
ReadCommented by Nico Popp on September 4th, 2020 | 09:48 CEST
Moderna, Evotec or Valeo Pharma: Who has the game changer?
The pandemic is driving the markets. But sometimes investors either come too late or bet on the wrong horse. In the analysis, three stocks for which investors hope for the game changer. The fact that the search for a cure for Covid-19 is making high waves on the stock market is shown by stocks like Moderna. Despite the current price correction, the biotech company from the USA achieves an annual performance of a massive 280%. The reason for this soaring performance is easy to find: Moderna is researching a Corona vaccine and has already reported promising interim results. Among other things, the EU has already secured several million vaccine doses in the event of a successful clinical approval procedure.
ReadCommented by Mario Hose on June 18th, 2020 | 08:40 CEST
BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?
Experienced investors assume that the DAX, Germany's leading index, will still reach new highs in 2020. One of the best-known supporters of this scenario is the asset manager Dr. Jens Ehrhardt. Rising markets are supported by the measures taken by central banks and politicians - it is de facto the consequence of the increase in the money supply. This expected development will be of particular interest to those investors who have so far been on the sidelines and have to position themselves or reallocate.
ReadCommented by Mario Hose on May 26th, 2020 | 07:43 CEST
BioNTech, Evotec, XPhyto - will the next rally start?
Germany's leading index DAX closed the previous day at 11,391 points, its highest level since March 2020. At the beginning of the week the index of the 30 largest German companies gained 317 points compared to Friday, representing a gain of 2.87%. In the USA Wall Street remained closed on Monday due to the Memorial Day. As is well known, the stock market is where the future is traded and for this reason investors are already investing in the prospects of companies in the period following the Corona Pandemic. A rally has begun.
Read